Connect Biopharma Holdings Limited
CNTB
$2.12
-$0.08-3.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -100.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -100.00% | |||
| SG&A Expenses | 11.83% | -35.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.37% | -12.25% | |||
| Operating Income | -26.28% | 12.17% | |||
| Income Before Tax | -28.30% | 12.00% | |||
| Income Tax Expenses | 77.78% | -55.74% | |||
| Earnings from Continuing Operations | -28.39% | 12.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.39% | 12.16% | |||
| EBIT | -26.28% | 12.17% | |||
| EBITDA | -26.71% | 12.30% | |||
| EPS Basic | -27.31% | 12.70% | |||
| Normalized Basic EPS | -27.25% | 12.58% | |||
| EPS Diluted | -27.31% | 12.70% | |||
| Normalized Diluted EPS | -27.25% | 12.58% | |||
| Average Basic Shares Outstanding | 0.85% | 0.63% | |||
| Average Diluted Shares Outstanding | 0.85% | 0.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||